Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2009

Oct 22, 2009

29777_dirs_2009-10-22_e29c79de-1b99-4cb4-addd-798ad9540525.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2009-10-20

Reporting Person: ROBERTS ROY S (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2009-10-20 Common shares without par value M 6413 $37.4229 Acquired 28033 Direct
2009-10-20 Common shares without par value S 1326 $52.051 Disposed 26707 Direct
2009-10-20 Common shares without par value S 2600 $52.032 Disposed 24107 Direct
2009-10-20 Common shares without par value S 1287 $52.031 Disposed 22820 Direct
2009-10-20 Common shares without par value S 100 $52.0319 Disposed 22720 Direct
2009-10-20 Common shares without par value S 600 $52.041 Disposed 22120 Direct
2009-10-20 Common shares without par value S 100 $52.0406 Disposed 22020 Direct
2009-10-20 Common shares without par value S 200 $52.0412 Disposed 21820 Direct
2009-10-20 Common shares without par value S 200 $52.0505 Disposed 21620 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2009-10-20 Option (right to buy) $37.4229 M 6413 Disposed 2013-04-24 Common shares (6413) Direct

Footnotes

F1: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.